Affiliation:
1. Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2. Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
3. Neurology Research center, Department of Neurology, Yasuj University of Medical Sciences, Yasuj, Iran
Abstract
Neurological disorders and their sequelae, as of the widespread and critical humans’
complications, affect the body's nervous systems, organ functions, and behaviors. According to
WHO, neurological disorders are currently predicted to affect more than one billion people globally.
It is well-established that complementary medicine is one of the high accepted interventions
that could have been considered for the management of neurological ailments. The current review
aimed to compile all the crucial data reporting the investigation on the conspicuous intervention of
green tea (made of Camellia sinensis) and related lead compounds (especially l-theanine, epigallocatechin-
3-gallate, epicatechin-3-gallate, epicatechin, and epigallocatechin) for their neurological
activities, mechanisms of action, and clinical properties. According to the documents, green tea exhibits
antidepressant, anti-neurodegenerative (e.g., anti-Parkinson and anti-Alzheimer), as well as
neuroprotective effects.Chief among them, for offering novel work, it is worth focusing on several
related assessments with great attention to more extensive standardized clinical trials, and subsequently
more in-depth pharmacokinetic studies to safely introduce this beneficial medicinal food as
a neuro-effective agent.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology,General Medicine
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献